Baruah P

References (4)

Title : Elevated Fibrinogen Level Reduces Therapeutic Efficiency of AD Drugs: Biophysical Insights into the Interaction of FDA-Approved Cholinesterase Inhibitors with Human Fibrinogen - Baruah_2021_J.Phys.Chem.B__
Author(s) : Baruah P , Paul D , Doshi J , Mitra S
Ref : J Phys Chem B , : , 2021
Abstract :
PubMedSearch : Baruah_2021_J.Phys.Chem.B__
PubMedID: 34964643

Title : Sulfonylurea Class of Antidiabetic Drugs Inhibit Acetylcholinesterase Activity: Unexplored Auxiliary Pharmacological Benefit toward Alzheimer's Disease - Baruah_2021_ACS.Pharmacol.Transl.Sci_4_193
Author(s) : Baruah P , Das A , Paul D , Chakrabarty S , Aguan K , Mitra S
Ref : ACS Pharmacol Transl Sci , 4 :193 , 2021
Abstract :
PubMedSearch : Baruah_2021_ACS.Pharmacol.Transl.Sci_4_193
PubMedID: 33615172

Title : Therapeutic potency of substituted chromones as Alzheimer's drug: Elucidation of acetylcholinesterase inhibitory activity through spectroscopic and molecular modelling investigation - Baruah_2019_Bioimpacts_9_79
Author(s) : Baruah P , Rohman MA , Yesylevskyy SO , Mitra S
Ref : Bioimpacts , 9 :79 , 2019
Abstract :
PubMedSearch : Baruah_2019_Bioimpacts_9_79
PubMedID: 31334039

Title : Novel Coumarin Derivatives as Potent Acetylcholinesterase Inhibitors: Insight into Efficacy, Mode and Site of Inhibition - Baruah_2018_J.Biomol.Struct.Dyn__1
Author(s) : Baruah P , Basumatary G , Yesylevskyy SO , Aguan K , Bez G , Mitra S
Ref : J Biomol Struct Dyn , :1 , 2018
Abstract :
PubMedSearch : Baruah_2018_J.Biomol.Struct.Dyn__1
PubMedID: 29663860